pharma · TTR-mediated Amyloidosis · Hypertension · ALNY
Alnylam Netherlands
Alnylam Netherlands B.V.
Alnylam Netherlands clinical programs — 84 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2002
- Employees
- 2,826
- Programs
- 84
- Drugs
- 37
- Patents
- 379
Alnylam Netherlands projects
84 ClinicalTrials.gov programs sponsored by Alnylam Netherlands.
Alnylam Netherlands has 84 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
VIR-2218
Alnylam Netherlands B.V.
Chronic Hepatitis B
2 trials -
VIR-2218
Alnylam Netherlands B.V.
Hepatitis B, Chronic
1 trial -
Zilebesiran
Alnylam Netherlands B.V.
High Cardiovascular Risk
1 trial -
Zilebesiran
Alnylam Netherlands B.V.
Mild to Moderate Hypertension
1 trial -
cemdisiran
Alnylam Netherlands B.V.
Atypical Hemolytic Uremic Syndrome
2 trials -
phosphate-buffered saline for SC administration
Alnylam Netherlands B.V.
Hereditary Hemorrhagic Telangiectasia (HHT)
1 trial -
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Netherlands B.V.
Advanced or Metastatic Hepatocellular Carcinoma
1 trial -
A Study to Evaluate ALN-HTT02 in Adult Patients with Huntington’s Disease
Alnylam Netherlands B.V.
Huntington’s disease
1 trial -
ALN-4285
Alnylam Netherlands B.V.
Healthy Volunteers
1 trial -
ALN-4915
Alnylam Netherlands B.V.
Healthy Volunteers
1 trial -
ALN-5288
Alnylam Netherlands B.V.
Alzheimer's Disease
1 trial -
ALN-5288-001
Alnylam Netherlands B.V.
Alzheimer’s Disease
1 trial -
ALN-AAT
Alnylam Netherlands B.V.
Antitrypsin Deficiency Liver Disease
1 trial -
ALN-AGT01
Alnylam Netherlands B.V.
Hypertension
1 trial -
ALN-AGT01 RVR
Alnylam Netherlands B.V.
Healthy Volunteers
1 trial -
ALN-APP
Alnylam Netherlands B.V.
Early-Onset Alzheimer Disease
1 trial -
ALN-APP-001
Alnylam Netherlands B.V.
Early-onset Alzheimer's disease (EOAD)
1 trial -
ALN-BCAT
Alnylam Netherlands B.V.
Advanced Hepatocellular Carcinoma
1 trial -
ALN-HBV
Alnylam Netherlands B.V.
Hepatitis B
1 trial -
ALN-HSD
Alnylam Netherlands B.V.
Nonalcoholic Steatohepatitis
1 trial -
ALN-HTT02
Alnylam Netherlands B.V.
Huntington's Disease
1 trial -
ALN-PCS02
Alnylam Netherlands B.V.
Elevated LDL-Cholesterol (LDL-C)
1 trial -
ALN-PCSSC
Alnylam Netherlands B.V.
Hypercholesterolemia
1 trial -
ALN-TTR01
Alnylam Netherlands B.V.
Transthyretin Mediated Amyloidosis (ATTR)
1 trial -
ALN-TTR02
Alnylam Netherlands B.V.
TTR-mediated Amyloidosis
1 trial -
ALN-TTRSC (revusiran)
Alnylam Netherlands B.V.
TTR-mediated Amyloidosis
1 trial -
ALN-TTRSC02
Alnylam Netherlands B.V.
Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
1 trial -
ALN-TTRSC04
Alnylam Netherlands B.V.
Transthyretin-Mediated Amyloidosis
1 trial -
ALN-VSP02
Alnylam Netherlands B.V.
Solid Tumors
2 trials -
Computer algorithm for ATTR
Alnylam Netherlands B.V.
Transthyretin Amyloidosis
1 trial -
Givosiran
Alnylam Netherlands B.V.
Acute Intermittent Porphyria (AIP)
1 trial -
Pozelimab
Alnylam Netherlands B.V.
Healthy
1 trial -
givosiran (ALN-AS1)
Alnylam Netherlands B.V.
Acute Intermittent Porphyria
1 trial -
patisiran
Alnylam Netherlands B.V.
Polyneuropathies
1 trial -
patisiran (ALN-TTR02)
Alnylam Netherlands B.V.
Transthyretin (TTR)-Mediated Amyloidosis
1 trial -
99mTc-pyrophosphate Scintigraphy
Alnylam Netherlands B.V.
Transthyretin Amyloidosis
1 trial
Frequently asked questions
How many clinical projects does Alnylam Netherlands have?
84 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.